2012 Press Releases

January 10, 2012 Wockhardt launches generic version of Rhinitis drug Flonase® nasal spray

2011 Press Releases

November 12, 2011 Wockhardt's Financial Results - Q2 (Jul-Sept) FY 2011-12 Wockhardt Sales up 18% and Operating Profit up 47% Net Profit was Rs 128 crore
August 9, 2011 Wockhardt's Financial Results - Q1 (April-June) FY 2011-12 Wockhardt's Operating Profit (EBIDTA) Rs 310.8 crore, a growth of 72.5% Net Profit Rs 193.9 crore Consolidated Sales grew by 14.3% to Rs 1,053.2 crore
July 8, 2011 Wockhardt receives tentative US FDA approval for generic version of depression drug Cymbalta®
July 1, 2011 Wockhardt receives tentative US FDA approval for generic version of Patanol® ophthalmic solution
June 21, 2011 Wockhardt launches three new products in three weeks, in the United States
May 19, 2011 Wockhardt's robust business backed with profits Consolidated Sales grew by 3.1% to Rs 3,751 crore Operating Profit (EBIDTA) grew by 41.7% to Rs 908.7 crore Net Profit was Rs 90.5 crore
April 25, 2011 Wockhardt receives US FDA approval for generic version of Aricept® tablets
April 19, 2011 Wockhardt receives US FDA approval for generic version of Effexor XR® capsules
February 02, 2011 Wockhardt's Q3 (October - December) FY 2011 Results Wockhardt bounces back with Profits Consolidated Sales Rs. 950.80 crore Net Profit Rs 141.7 crore Operating Profit grows at 82.0% (EBIDTA Rs 243.7 crore)

2010 Press Releases

November 12, 2010 Wockhardt's Q2 (July - September) FY 2011 Consolidated Sales Rs 940.1 crore Operating Profit (EBIDTA) Rs 219.8 crore Wockhardt's India, UK & US businesses post double-digit growth
October 20, 2010 Wockhardt receives US FDA approval for the generic version of Allegra-D® 12 hour
August 13, 2010 Wockhardt's Q1 (Apr-Jun) FY 2011 Consolidated Sales was Rs 922 crore Operating Profit (EBIDTA) was Rs 180 crore Wockhardt's US, UK & India Branded Business posts double-digit growth
July 23, 2010 Wockhardt receives US FDA approval for the generic version of Toprol XL® , a cardiac drug
May 20, 2010 Wockhardt's 15 months Sales stood at Rs 4,501 crores and Operating Profit at Rs 823 crores
May 15, 2010 Purdue University confers Habil Khorakiwala an honorary doctorate in Pharmacy
April 28, 2010 Wockhardt launches Prostate drug Tamsulosin capsules in the United States
January 25, 2010 Wockhardt's Q4 Results 2009
January 13, 2010 Wockhardt receives US FDA approval for antibacterial Levofloxacin
January 06, 2010 Wockhardt receives US FDA approval for Alzheimer's drug Memantine

2009 Press Releases

November 18, 2009 Wockhardt launches anti-hypertensive drug Nicardipine injections in USA
October 31, 2009 Wockhardt's Q3 Results 2009
October 01, 2009 Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets
September 29, 2009 Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules
July 30, 2009 Wockhardt’s Q2 Results 2009
April 24, 2009 Wockhardt’s 2008 Annual Results
February 26, 2009 Wockhardt to launch generic version of ulcer drug Ranitidine syrup in the US market
February 12, 2009 Wockhardt to launch Leveiracetam, a generic version of epilepsy drug in the US market
February 11, 2009 Wockhardt to launch Divalproex ER in the US market

2008 Press Releases

December 4, 2008 Wockhardt receives US FDA approval for generic version of Augmentin* Suspension
November 13, 2008 Wockhardt launches Midazolam in the US market
October 21, 2008 Wockhardt’s Q3 Results 2008
October 16, 2008 Wockhardt gets US FDA nod to market Ceftazidime injections
July 28, 2008 Wockhardt’s Q2 Results 2008
April 28, 2008 Wockhardt’s Q1 Results 2008
February 13, 2008 Wockhardt enters the US market with generic version of Zithromax
January 9, 2008 Wockhardt to launch generic version of anti-depressant Zoloft in the US Market
January 1, 2008 Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US

2007 Press Releases

October 27, 2007 Wockhardt acquires Morton Grove in the US
September 18, 2007 Wockhardt gets US FDA nod to enter the US$ 2.6 billion Norvasc market
July 09, 2007 Wockhardt to launch anti-epileptic injection, Fosphenytoin, in the US
June 20, 2007 Wockhardt to launch Cefprozil in the US
June 06, 2007 Wockhardt gets US FDA nod to enter the $680 million Lamisil market
  2011, Wockhardt USA, All Rights Reserved
Legal Disclaimer    |    Terms of Use    |    Privacy Policy